Clareon TruPlus vs Tecnis Eyhance IOLs for cataract surgery
Official title: Visual and Patient Reported Outcomes Comparing Clareon TruPlus IOL and Tecnis Eyhance IOLs in Normal Cataract Patients: Stage 1
Run by Gainesville Eye Associates · NCT07658040 · Data updated 2026-11-12
This study compares two types of intraocular lenses implanted in both eyes of adults with cataracts to see which provides better vision after three months.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 70 (estimated) |
| Sponsor | Gainesville Eye Associates Academic / other |
| Locations | 1 site (Gainesville, Georgia) |
| Status | Recruiting |
| Started | July 20, 2026 |
| Main results expected | August 9, 2027 |
| Study ends | August 9, 2027 |
| Registry record updated | September 1, 2026 |
| Trial ID | NCT07658040 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with bilateral age-related cataracts planning simultaneous bilateral cataract surgery and meeting strict vision and astigmatism criteria.
✕Probably not a fit
Patients with irregular corneas, macular or retinal diseases, glaucoma, severe dry eye, or other conditions not compatible with the study criteria may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a prospective, randomized, two-arm, single-center, single-surgeon study that doubles-masks both participants and assessors. Participants will undergo bilateral cataract removal with implantation of either Clareon TruPlus IOL or Tecnis Eyhance IOL, followed by a 3-month postoperative assessment. The study collects pre-operative and postoperative data to compare outcomes related to vision and refractive results. It will be conducted at one site with a single surgeon to minimize variability. Key eligibility requires bilateral cataracts, acceptable expected postoperative visual acuity, and residual astigmatism within target ranges.
Why it matters
Potential benefit: If successful, patients may experience improved postoperative visual outcomes with one of the IOL options, potentially guiding lens choice for future surgeries.
How similar studies have gone: Prior studies with similar IOL comparisons have shown variable but informative results; this design’s double-masked approach aims to reduce bias, though direct, large-scale replication is limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Willing and able to understand and sign informed consent. * Adult patient diagnosed with age-related cataracts bilaterally. * Planned bilateral cataract removal and with bilateral implantation of the Clareon TruPlus IOL/Toric BLF (T3-T5) or Tecnis Eyhance IOL/Eyhance Toric (equivalent to T3-T5). * Best monocular corrected distance visual acuity expected to be 0.1 logMAR (Snellen 20/25) or better in both eyes postoperatively as determined by surgeon. * Residual astigmatism expected to be \<= 0.50 diopters in both eyes postoperatively as determined by surgeon (After using either toric IOL or arcuate incision with laser or manual LRI). * Normal ocular findings aside from cataract. Exclusion Criteria: * Moderate-severe corneal pathology, irregular astigmatism, preexisting macular disease and other retinal degenerative diseases expected to cause future vision loss, glaucoma, severe dry eye disease, nystagmus, strabismus, zonular laxity or dehiscence, pseudoexfoliation. * Previous history of any ocular surgery including corneal refractive surgery. * History of amblyopia or monofixation syndrome with poor stereoscopic vision. * Participants desiring monovision. * Any planned simultaneous/combined procedures at time of cataract surgery (e.g. MIGs). * Participation in another clinical study that could interfere with the results. * Any active ocular infection or inflammation.
Where it's running
-
North Georgia Eye Associates
Gainesville, Georgia, United States Recruiting
Study contacts
- Principal investigator: Clayton Blehm, MD — North Georgia Eye Associates
- Study coordinator: Maryann Thomas
- Email: maryann.thomas@ngeye.com
- Phone: 770-532-4444
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Rotational Stability of the Acunex Vario Toric
This study tests whether the Acunex Vario toric extended-depth-of-focus intraocular lens stays stable in rotation and effectively reduces astigmatism for people undergoing cataract surgery.
-
Anterior segment anatomy assessment with swept-source OCT in eye surgery patients
This study tests whether swept-source OCT can detail front-eye anatomy in patients undergoing anterior segment eye surgery.
-
MiLOOP-assisted cataract surgery for dense cataracts
In people with dense cataracts, this study tests whether using the miLOOP device during cataract surgery can protect corneal cells and reduce ultrasound energy, compared with standard surgery.
-
Visual adaptation and quality of life after different IOL implantation options
This study follows adults who have cataracts and receive bilateral multifocal or mixed IOLs to see how their vision and daily life improve over 6 months.
-
Corneal Biomechanics and Surgical Astigmatism after Cataract Surgery in Pseudoexfoliation
This study tests how the cornea's biomechanical properties before cataract surgery relate to the amount of blinking surgically induced astigmatism, comparing people with pseudoexfoliation to those without.
-
Neuroplastic pain education and guided breathing during awake cataract surgery
This trial tests whether the STEIN Protocol, a non-drug approach with pain education, guided imagery, and paced breathing, helps adults having cataract surgery require less pain medicine and feel less anxious.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.